DR. STEVEN LELAND MCCUNE, MD, PHD

Plain English
This research looked at the genetic material of 35 types of fungi that come from various plants. The findings reveal important details about how these fungi grow and adapt to new plants. Understanding this process can help improve agricultural practices and manage plant health. Who this helps: Farmers and agricultural researchers.

Plain English
This study looked at how existing health issues (comorbidities) affect patients with hormone receptor-positive, HER2-negative advanced breast cancer who were treated with a drug called palbociclib. It found that patients with fewer comorbidities had better outcomes; for example, those with no comorbidities had a median progression-free survival of 20.3 months compared to just 16.8 months for those with three or more comorbidities. Importantly, the overall quality of life for patients remained stable, regardless of their comorbidities. Who this helps: This information benefits doctors and healthcare providers in managing treatment for advanced breast cancer patients.

Plain English
This study looked at different types of breast cancer to understand the unique ways in which they process energy, especially before and after treatment with a common chemotherapy drug called doxorubicin. Researchers found that triple-negative breast cancer (TNBC) and metastatic cells used energy in ways that differed significantly from other breast cancer types, making them less responsive to treatment. For example, TNBC cells showed a strong reliance on certain energy sources. Who this helps: This research benefits patients with breast cancer by paving the way for more effective and personalized treatment options.

Plain English
This research examined the effectiveness of a treatment combining palbociclib with hormone therapy for patients with advanced breast cancer that is hormone receptor-positive and HER2-negative. The study involved 1,250 patients, showing that 34% of those in their first round of treatment had a positive response, with the treatment helping patients live a median of 20.9 months without their disease worsening, while those who had already received treatment before had lower rates of response and a median progression-free survival of 13.5 months. These findings are important because they confirm that this treatment works well in real-world settings, supporting its use for a diverse group of breast cancer patients who might not have been represented in clinical trials. Who this helps: This benefits patients with HR+/HER2- advanced breast cancer and their healthcare providers.

Plain English
The study looked at the challenges involved in developing medications for children, highlighting issues like lack of funding and difficulties in conducting clinical trials. Researchers found that many pharmaceutical companies are shifting their focus to adult drugs, resulting in fewer resources for pediatric drug development. This matters because children have unique health needs, and without adequate research, they may not receive effective treatments. Who this helps: This helps children and their families by encouraging better access to safe and effective medications.

Plain English
This study evaluated a new, fast testing method for detecting a tough fungal infection that can spread in hospitals, using swabs from the nose, armpits, and groin. The new test showed impressive accuracy: it correctly identified the infection 94% of the time compared to a well-established test, which is crucial for controlling outbreaks in healthcare settings. Being able to test over 1,000 samples in just eight hours could help prevent the spread of this dangerous fungus. Who this helps: Patients in hospitals and healthcare workers.

Plain English
The study looked at a new screening process for donor human milk before it was pasteurized to reduce the amount discarded due to contamination. After implementing this protocol, the amount of milk thrown away went down from about 10.7% to only 3.1%, resulting in an estimated savings of around $323,800 over three years. This matters because it means more nutritious milk is available for preterm infants, who rely on it for their health. Who this helps: This helps premature infants who need donor milk for nutrition.

Plain English
This study looked at how a lack of protein in a mother's diet during pregnancy affects the behavior and brain development of her offspring. It found that mice born to mothers with low protein diets showed problems with cognition and anxiety later in life. Importantly, the researchers discovered that the mother's gut bacteria and nutrient profiles changed due to the low protein diet, which also influenced the offspring's brain development. Who this helps: This research benefits expectant mothers and healthcare providers by highlighting the importance of maternal nutrition for child development.

Plain English
This study focused on older patients (70 years and older) with advanced breast cancer who were treated with the drug palbociclib. Out of 287 older patients, about 40% maintained a perfect performance status (ECOG score of 0) after six months, and their overall functional status did not decline significantly during treatment. This is important because it shows that older patients can tolerate this treatment without losing their ability to carry out daily activities. Who this helps: This helps older patients with breast cancer and their healthcare providers.

Plain English
This study looks at how to improve platform trials, which test multiple new treatments at the same time against a control group, like those used for COVID-19. The researchers found that using a digital research environment (DRE) can help solve challenges related to sharing sensitive data and protecting intellectual property, making it easier to conduct these trials safely and efficiently. This matters because it could speed up the approval of new treatments, ultimately improving patient care. Who this helps: Patients in need of new therapies.

Plain English
This study looked at how well COVID-19 At-Home Test kits work after being exposed to very hot or cold temperatures, which can happen during shipping. The researchers found that even after being stored in extreme conditions for up to two weeks, the tests still correctly identified all positive and negative samples, showing strong results every time. This matters because it means people can trust the test results even if the kits have been through temperature changes during delivery. Who this helps: Patients needing reliable COVID-19 testing at home.

Plain English
This study looked at how human milk oligosaccharides (HMOs) affect the measurement of lactose and total carbohydrates in human milk. Researchers tested 16 samples of human milk with and without HMOs using various methods and found that two specific scientific methods for measuring lactose gave very similar results and were not affected by HMOs. However, other methods reported higher carbohydrate levels when HMOs were present, which could lead to incorrectly estimating the milk's energy content. Who this helps: This research benefits healthcare providers and nutritionists who assess the nutritional value of human milk.

Plain English
This study looked at how donor human milk (DHM) stored in the refrigerator changes over four days, especially regarding its nutrients and any bacterial growth after being treated to kill bacteria. Researchers found that the levels of key nutrients like lactose and protein, as well as immunoglobulin A (IgA), remained stable over time, and 81% of samples had very low bacterial growth (less than 10 colony-forming units). In contrast, infant formula showed high bacterial counts throughout the study. This matters because it suggests that low-bacteria DHM can be a safe and nutritious option for feeding healthy infants, especially when demand is high. Who this helps: This helps infants who receive donor human milk, their families, and healthcare providers.

Plain English
This study focused on a transgender woman who successfully induced lactation using a specific treatment plan that included medications and breast pumping. The findings showed that her breastmilk contained similar nutrients to that of a typical gestational parent, making it a viable option for feeding her baby. This is important because it expands the possibilities for transgender and gender-diverse individuals who want to participate in feeding their infants. Who this helps: Transgender and gender-diverse parents who wish to breastfeed.

Plain English
This study looked at the effectiveness of a new treatment combining telaglenastat and everolimus for patients with advanced kidney cancer (renal cell carcinoma) who had already received multiple prior treatments. The results showed that patients receiving this combination treatment had a median progression-free survival (the time without disease worsening) of 3.8 months, compared to just 1.9 months for those receiving a placebo. This finding indicates that the new treatment could help prolong life for patients with this difficult-to-treat cancer. Who this helps: This benefits patients with advanced renal cell carcinoma who have exhausted other treatment options.

Plain English
This study looked at the effects of combining two drugs, venetoclax and fulvestrant, on women with a specific type of advanced breast cancer that wasn't responding to prior treatments. Researchers found that the combination did not significantly improve outcomes: the clinical benefit rate was 11.8% for those taking both drugs compared to 13.7% for those on fulvestrant alone. Median progression-free survival was slightly longer for the combination (2.69 months) versus fulvestrant alone (1.94 months), but the difference was not statistically meaningful. Who this helps: This research helps doctors understand that this drug combination is not effective for patients with this type of breast cancer.

Plain English
This study looked at how pediatric clinical research networks help speed up the development of medicines for children. It found that these networks are well-organized and focused on meeting the specific needs of drug developers and academic researchers, making it easier to conduct high-quality trials across different regions like the U.S., Europe, Japan, and Canada. This is important because it leads to faster access to new treatments for young patients with various conditions. Who this helps: This helps children and their healthcare providers by improving access to new and effective medications.

Plain English
Researchers examined the use of donor human milk (DHM) for infants who are not preterm, reviewing 26 studies published over a 20-year period. They found that while some small studies suggested that DHM might benefit infants with health issues, there was little consistent data regarding its effects on healthy infants, especially regarding growth and breastfeeding success. This matters because understanding the benefits of DHM for a wider range of infants could improve their nutrition and health outcomes. Who this helps: This helps parents and healthcare providers caring for infants beyond just preterm babies.

Plain English
This study focused on the necessary clinical research for developing safe and effective medications for children. Researchers and officials from the FDA discussed how to ensure that pediatric trials offer clear benefits to child participants to justify the risks involved. They identified challenges in assessing these benefits, and proposed strategies to address them, like using data from adult studies and advanced modeling techniques. Who this helps: This helps children participating in clinical trials, their families, and the doctors who treat them.

Plain English
This study looked at how the aging process in people and their dogs affects each other, especially focusing on improving quality of life as we age. It found that fostering strong relationships between older adults and dogs can enhance well-being for both, but challenges arise as they grow older. Understanding this relationship can help develop better support systems and alternatives for seniors who may not be able to care for a pet anymore. Who this helps: This benefits older adults and their caregivers.

Plain English
This study examined two different dosing schedules of medications for patients with advanced melanoma who had not yet been treated. Researchers found that using pembrolizumab with ipilimumab at a dose of 50 mg every six weeks led to 55% of patients responding well to treatment, while the 100 mg dose every twelve weeks had a 61% response rate. The lower dose of ipilimumab also resulted in fewer severe side effects (24% compared to 39% for the higher dose), which means this combination could be a safer option for patients. Who this helps: This helps melanoma patients seeking effective treatment with fewer side effects.

Plain English
This study compared a new treatment called spartalizumab to traditional chemotherapy for patients with a type of cancer called nasopharyngeal cancer that has come back after other treatments. Researchers found that although patients taking spartalizumab had a shorter median time without disease progression—1.9 months compared to 6.6 months with chemotherapy—those on spartalizumab lived longer overall (25.2 months compared to 15.5 months for chemotherapy) and had a longer response duration (10.2 months versus 5.7 months). These results are important because they highlight that while spartalizumab might not stop the cancer as effectively in the short term, it can extend the overall life of patients. Who this helps: This helps patients with recurrent nasopharyngeal cancer seeking alternative therapy options.

Plain English
This paper discusses a new guide released by the European Medicines Agency and the US Food and Drug Administration aimed at improving how new cancer drugs for children are developed and approved. The guide encourages companies to submit plans for studying these drugs in children at the same time as they submit their plans for adult studies. This is important because it streamlines the drug approval process, potentially getting new treatments to young patients more quickly. Who this helps: This benefits young cancer patients and their families by speeding up access to new treatments.

Plain English
This study created a database to collect information about children and teenagers with migraines, aged 4 to 17. The goal is to gather real-world data that can help test new migraine treatments and support their approval for pediatric use. By bringing together various experts and organizations, they were able to start enrolling patients within just six months, making it easier to gather critical data on how these new treatments work in young patients. Who this helps: This benefits patients with migraines, their families, and healthcare providers by providing better treatment options.

Plain English
This study looked at whether using a specific blood testing machine (cobas e 602) to screen for diseases like hepatitis C (HCV), hepatitis B (HBV), and HIV risks contaminating samples with viral materials. The researchers tested 480 negative specimens and found no signs of contamination, meaning the testing method is safe. This matters because it allows doctors to use the same sample for both initial screening and more in-depth testing without worrying about contamination, making the process simpler and more efficient. Who this helps: Patients and healthcare providers involved in diagnosing viral infections.

Plain English
This study looked at how a protein called Oct4 interacts with another protein, Lsd1, to influence gene activity in cancer stem cells. The researchers found that when Oct4 levels were increased, it reduced Lsd1's ability to modify certain genes, keeping them in a more active state. This is important because it shows that Oct4 can play a role in maintaining a state that may contribute to the aggressiveness of cancer stem cells. Who this helps: This helps doctors and researchers working on cancer treatments.

Plain English
This study looked at how poverty affects biological signs of stress in the body, known as biomarkers. Out of 63 relationships examined, 17 showed a clear link between poverty and these stress markers, and 12 more hinted at a connection. This matters because it highlights that living in poverty is not just a financial issue but also harms physical health through increased stress. Who this helps: This helps patients living in poverty and healthcare providers addressing their needs.

Plain English
This study looked at how to determine the right drug doses for newborns, focusing on the differences in drug development for neonates compared to older children and adults. It found that for medications like meropenem, which are used for infections, the approach to dosing differs significantly, as information from older patients is rarely used for newborns. Understanding the best dosing for newborns is crucial because their bodies process medications differently, affecting both safety and effectiveness. Who this helps: This helps doctors and healthcare providers who treat newborns.

Plain English
This study focused on improving treatments for breathing problems that affect babies born prematurely. Researchers found that current methods for measuring these health issues are not very effective, which makes it hard to create better therapies. They proposed a plan to better define what outcomes are meaningful in treating these conditions, highlighting the need for collaboration among different groups working on this issue. Who this helps: This benefits premature babies and their healthcare providers.

Plain English
This study looked at how long clinical trials for drugs used in children were conducted before getting approval from the FDA. Researchers examined 306 trials for 86 drugs and found that the average trial lasted 44 weeks, with most (61%) lasting under a year, but 12% lasted three years or more. These findings highlight that many trials may not last long enough to fully assess the safety of drugs that children will use for a long time. Who this helps: Children with chronic diseases and their healthcare providers.

Plain English
This study examines how including pediatric patients and their families in drug development can improve clinical trials for children. It highlights that although recent laws in Europe and North America aim to involve children in these processes, there are still many barriers preventing their meaningful participation. The research emphasizes the need for better guidelines to ensure that children's perspectives are heard, which can lead to safer and more effective medications specifically designed for them. Who this helps: This helps pediatric patients and their families by ensuring their needs and experiences are considered in drug development.

Plain English
This study tested whether atezolizumab, a drug that boosts the immune system, combined with chemotherapy could help people with advanced non-small-cell lung cancer live longer compared to chemotherapy alone. The results showed that patients who received atezolizumab along with chemotherapy had a median overall survival of 18.6 months, compared to 13.9 months for those who just received chemotherapy. Additionally, those on the combination therapy experienced a median progression-free survival of 7.0 months versus 5.5 months for chemotherapy alone. This research is important because it offers a more effective treatment option for patients with this type of lung cancer, potentially improving their life expectancy and quality of life. Who this helps: This benefits patients with advanced non-small-cell lung cancer and their doctors.

Plain English
This study examined whether contamination of a specific flu testing device could lead to false-positive results, which might misguide treatment for patients. Researchers intentionally contaminated the testing system with flu material but then found that the tests still provided accurate results—no flu was detected in the negative control samples, even after the contamination. This is important because it means that healthcare providers can trust the results from this device even in the event of contamination, reducing the risk of misdiagnosis and incorrect treatment. Who this helps: This helps patients and doctors by ensuring accurate flu testing results.

Plain English
This study looked at whether having a dog or walking a dog affects the fitness and weight of children aged 9 to 10 years. Researchers found that children who live with or walk dogs are not noticeably fitter or less likely to be overweight compared to those without dogs. This matters because it suggests that simply having a dog or walking it isn’t enough to improve children's health and fitness levels. Who this helps: Parents and caregivers of children looking for ways to improve their kids' fitness and weight.

Plain English
This research paper focuses on how new laws have helped gather information on over 600 medications for newborns and children, ensuring these drugs are effective and safe for young patients. Despite progress, many clinical trials for kids still don't meet their goals, and there are ongoing delays in starting these important studies. Improving how drugs are tested and chosen for children is crucial for their health and treatment options. Who this helps: This benefits children and their doctors.

Plain English
This study looked at how having pets affects community connections and social networks in four different cities. Researchers found that people who own pets have stronger social ties and community engagement, with this trend seen in both the U.S. and Australia, not just among dog owners or those who walk dogs. This matters because it highlights that pets can play a valuable role in helping people connect with each other and strengthen their communities. Who this helps: This helps pet owners and communities looking to enhance social interactions.

Plain English
This study looked at how walking dogs affects physical activity and people's feelings of safety in neighborhoods across four cities: three in the US (San Diego, Nashville, and Portland) and one in Australia (Perth). Results showed that dog owners walked their dogs 5-6 times a week for a total of about 93-109 minutes each week, which helped them get more exercise compared to those who didn’t walk dogs. Dog walkers in the US felt safer in their neighborhoods than those in Perth, highlighting the importance of dog walking not just for health but also for enhancing neighborhood safety and community bonding. Who this helps: This benefits dog owners and communities looking to improve health and safety.

Plain English
This study looked at how spending time with therapy dogs can improve the physical and mental well-being of older adults with mild to moderate cognitive impairment living in assisted living facilities. Residents who participated in regular dog visits showed more improvement in physical activity and symptoms of depression compared to those who engaged in reminiscence therapy. This is important because it shows that pet therapy can help maintain the health and quality of life for these residents, potentially delaying the need for more intensive care. Who this helps: This helps elderly residents with cognitive impairment and their caregivers.

Plain English
This study looked at the reduced levels of a brain chemical called somatostatin (SST) in a part of the brain known as the subgenual anterior cingulate cortex (sgACC) in people with major depression. The researchers found that while the number of neurons producing SST didn't change, the amount of SST per neuron was lower across all layers of the cortex, with the most significant differences seen in female subjects. This matters because understanding the reduced SST levels can provide insights into how depression affects brain function. Who this helps: This research benefits patients with major depression and their doctors by improving knowledge of depression's biological basis.

Plain English
The study looks at how the FDA is improving its processes for getting new drugs approved. Over the past decade, the FDA has launched several initiatives aimed at making drug development faster and more efficient, with ongoing projects benefiting from collaboration with various stakeholders. This matters because these improvements can help bring new treatments to patients more quickly and safely. Who this helps: This helps patients, doctors, and the healthcare system by potentially speeding up access to new medications.

Plain English
This study looked at how owning pets can help people meet and form friendships with others in their neighborhoods. Researchers found that pet owners were 61% more likely to get to know their neighbors compared to non-pet owners, and dog owners in specific U.S. cities were more likely to consider those they met through their pet as friends. Approximately 40% of pet owners received various types of social support from these connections, highlighting how pets can enhance social interactions and community well-being. Who this helps: This benefits pet owners and their communities by fostering friendships and support networks.

Plain English
This study looked at how the FDA is making it easier to use biomarkers—biological indicators that can help in drug development—by establishing a program called the Biomarker Qualification Program (BQP). It found that once a biomarker is qualified for a specific use, it can be used across various drug development efforts without needing to go through the approval process again. This matters because it can speed up the development of new drugs, ultimately helping patients get access to better treatments more quickly. Who this helps: Patients and drug developers.